Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01597128 · ClinicalTrials.gov registry record · NA
Feasibility Study of The Use of FLEX HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrix in The Closure of Abdominal Wall Defects With Component Separation in Clean or Contaminated Cases
A NA study, sponsored by John Roth.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT01597128 is a NA study that has completed, run by John Roth. The registered enrollment target is 35 participants.
The verdict
NCT01597128, a NA study, has completed, sponsored by John Roth.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This study examines the feasibility of using Flex HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrixin the repair of hernias.
Interventions
- DEVICE Strattice
- DEVICE Flex HD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2011-03 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01597128
The ClinicalTrials.gov registry entry for NCT01597128 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is John Roth, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Strattice is the first listed.
NCT01597128 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01597128 about?
NCT01597128 is a clinical study titled "Feasibility Study of The Use of FLEX HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrix in The Closure of Abdominal Wall Defects With Component Separation in Clean or Contaminated Cases". This study examines the feasibility of using Flex HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrixin the repair of hernias.
What is the current status of trial NCT01597128?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2011-03. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01597128?
The interventions under investigation include: Strattice (DEVICE), Flex HD (DEVICE).
Who is sponsoring clinical trial NCT01597128?
This trial is sponsored by John Roth, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.